is tirzepatide a lifelong drug Peptide? How It Compares How the weight loss drug

This was compared with increasing a patients dose of the drug dulaglutide

A New Avenue for Addiction Treatment GLP-1 drugs may be a great new tool to help people combat alcohol use disorder

The key milestones include: exenatide approval (2005), liraglutide approval (2010), semaglutide injection approval (2017), oral semaglutide with SNAC approval (2019), orforglipron cryo-EM structure published (2020), orforglipron Phase 2 results in NEJM (2023), orforglipron Phase 3 ATTAIN-1 results in NEJM (2025), and FDA regulatory submission (2025)

Women tell us this is when they catch themselves smiling at small things again

Serve less first